Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis

BACKGROUND: Pulmonary endothelial injury and microcirculatory thromboses likely contribute to hypoxemic respiratory failure, the most common cause of death, in patients with COVID‐19. Randomized controlled trials (RCTs) suggest differences in the effect of therapeutic heparin between moderately and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sholzberg, Michelle, da Costa, Bruno R., Tang, Grace H., Rahhal, Hassan, AlHamzah, Musaad, Baumann Kreuziger, Lisa, Ní Áinle, Fionnuala, Almarshoodi, Mozah Obaid, James, Paula D., Lillicrap, David, Carrier, Marc, Beckett, Andrew, Fralick, Michael, Middeldorp, Saskia, Lee, Agnes Y. Y., Thorpe, Kevin E., Negri, Elnara Márcia, Cushman, Mary, Jüni, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681879/
https://www.ncbi.nlm.nih.gov/pubmed/34977448
http://dx.doi.org/10.1002/rth2.12638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681879/
https://www.ncbi.nlm.nih.gov/pubmed/34977448
http://dx.doi.org/10.1002/rth2.12638

Ejemplares similares